SK
SkinHealth Systems Inc.
SKIN · NASDAQ
$0.68 +1.50% (+$0.01)
1M +3.32%
Market Cap $88.1M
P/E Ratio -
Div. Yield -
ROE 47.84%
Bulios Fair Price
$0.94
39.3% upside
Current Price
$0.68
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SKIN is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
95 /100
Cheap P/B 1.59x
EV/EBITDA 8.62x
P/FCF 5.30x
Growth
0 /100
Declining Book val. growth 28.49%
Rev. growth 6.32%
FCF growth N/A
Profitability
33 /100
Weak Op. margin 1.49%
Gross margin 66.34%
FCF margin 5.74%
Quality
8 /100
Poor ROA 5.84%
ROIC 1.21%
Asset turnover 0.60x
Debt
13 /100
High Int. coverage 0.06x
Debt/Equity 6.60x
Net debt/EBITDA 5.57x
Stability
46 /100
Moderate EPS volatility 164.28%
Beta 1.00x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SKIN
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Pedro Malha
Employees
613
Headquarters
Long Beach
Upcoming events
05 NOV
Earnings
Upcoming earnings report